These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7539243

  • 1. Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy.
    Moreira LF, Naomoto Y, Hamada M, Kamikawa Y, Orita K.
    Anticancer Res; 1995; 15(2):639-44. PubMed ID: 7539243
    [Abstract] [Full Text] [Related]

  • 2. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H.
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [Abstract] [Full Text] [Related]

  • 3. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
    Giatromanolaki A, Koukourakis M, Zaramboukas T, Skordalaki A, Arapantoni P, Georgoulias V, Fountzilas G.
    Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H, Natsugoe S, Matsumoto M, Yokomakura N, Uchikado Y, Takatori H, Ishigami S, Takao S, Aikou T.
    J Surg Oncol; 2005 Jul 01; 91(1):84-9. PubMed ID: 15999354
    [Abstract] [Full Text] [Related]

  • 5. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
    Garzetti GG, Ciavattini A, Provinciali M, Di Stefano G, Lucarini G, Goteri G, Biagini G.
    Anticancer Res; 1996 Jul 01; 16(5B):3229-34. PubMed ID: 8920796
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F.
    Clin Cancer Res; 1995 Nov 01; 1(11):1375-83. PubMed ID: 9815934
    [Abstract] [Full Text] [Related]

  • 8. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K, Behera D.
    Lung Cancer; 2004 Aug 01; 45(2):181-8. PubMed ID: 15246189
    [Abstract] [Full Text] [Related]

  • 9. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
    Bottini A, Berruti A, Bersiga A, Brizzi MP, Brunelli A, Gorzegno G, DiMarco B, Aguggini S, Bolsi G, Cirillo F, Filippini L, Betri E, Bertoli G, Alquati P, Dogliotti L.
    Clin Cancer Res; 2000 Jul 01; 6(7):2751-8. PubMed ID: 10914720
    [Abstract] [Full Text] [Related]

  • 10. Spontaneous and inducible apoptosis in oesophageal adenocarcinoma.
    Raouf A, Evoy D, Carton E, Mulligan E, Griffin M, Sweeney E, Reynolds JV.
    Br J Cancer; 2001 Nov 30; 85(11):1781-6. PubMed ID: 11742502
    [Abstract] [Full Text] [Related]

  • 11. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma.
    Nakashima S, Natsugoe S, Matsumoto M, Kijima F, Takebayashi Y, Okumura H, Shimada M, Nakano S, Kusano C, Baba M, Takao S, Aikou T.
    Anticancer Res; 2000 Nov 30; 20(3B):1933-7. PubMed ID: 10928129
    [Abstract] [Full Text] [Related]

  • 12. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 30; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 13. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
    Sarbia M, Stahl M, Fink U, Willers R, Seeber S, Gabbert HE.
    Clin Cancer Res; 1998 Dec 30; 4(12):2991-7. PubMed ID: 9865911
    [Abstract] [Full Text] [Related]

  • 14. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
    Nakamori M, Iwahashi M, Nakamura M, Yamaue H.
    J Surg Oncol; 2003 Sep 30; 84(1):10-6. PubMed ID: 12949985
    [Abstract] [Full Text] [Related]

  • 15. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
    Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K, Oka M.
    Br J Cancer; 1999 Oct 30; 81(3):469-75. PubMed ID: 10507772
    [Abstract] [Full Text] [Related]

  • 16. Expression of Bax and apoptosis-related proteins in human esophageal squamous cell carcinoma including dysplasia.
    Kurabayashi A, Furihata M, Matsumoto M, Ohtsuki Y, Sasaguri S, Ogoshi S.
    Mod Pathol; 2001 Aug 30; 14(8):741-7. PubMed ID: 11504832
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
    Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnell TJ.
    Clin Cancer Res; 1997 Oct 30; 3(10):1823-9. PubMed ID: 9815569
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.